Becton, Dickinson and CoBDXB.PFD +1.39%78 OCF Margin % is 12.73% as of Mar. 2026, which is 33% below its 10-year median of 19.04. GuruFocus rates BDXB.PFD with a GF Score™ of 78/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Becton, Dickinson and Co ranks better than 74.23% on this metric.
The historical rank and industry rank for Becton, Dickinson and Co's OCF Margin % or its related term are showing as below:
During the past 13 years, the highest OCF Margin % of Becton, Dickinson and Co was 24.30%. The lowest was 13.95%. And the median was 19.04%.
BDXB.PFD's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86 * Ranked among companies with meaningful OCF Margin % only.
Becton, Dickinson and Co OCF Margin % Related Terms
Becton, Dickinson and Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton, Dickinson and Co (BDXB.PFD) has a OCF Margin % of 12.73% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Becton, Dickinson and Co and its competitors. This is 33% below median its historical median of 19.04. Over the past decade, Becton, Dickinson and Co's OCF Margin % has ranged from 13.95 to 24.30. According to the industry distribution chart, Becton, Dickinson and Co ranks #210 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 25.8%.
Is Becton, Dickinson and Co's OCF Margin % too high?
Becton, Dickinson and Co's current OCF Margin % of 12.73% is 33% below median its 10-year median of 19.04. Over the past 10 years, this metric has ranged from a low of 13.95 to a high of 24.30. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Becton, Dickinson and Co's value of 12.73% is 117.2% above this industry median. Based on the distribution chart, Becton, Dickinson and Co ranks #210 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Becton, Dickinson and Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Becton, Dickinson and Co's OCF Margin % compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton, Dickinson and Co ranks #210 out of 815 companies for OCF Margin %. This puts Becton, Dickinson and Co in the upper half of its industry. The industry median OCF Margin % is 5.86. Becton, Dickinson and Co's value of 12.73% is 117.2% above this benchmark. Historically, Becton, Dickinson and Co's own OCF Margin % has ranged from 13.95 to 24.30 over the past decade. While the company's 10-year median is 19.04 vs. the industry median of 5.86, Becton, Dickinson and Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton, Dickinson and Co's current OCF Margin % of 12.73% is 117.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Becton, Dickinson and Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton, Dickinson and Co's current OCF Margin % is 12.73%, which is 33% below median its own 10-year median of 19.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton, Dickinson and Co stock overvalued right now?
Becton, Dickinson and Co (BDXB.PFD) has a current OCF Margin % of 12.73%. The current OCF Margin % is 12.73%, which is 33% below median its 10-year median of 19.04 and 117.2% above the Medical Devices & Instruments industry median of 5.86. Becton, Dickinson and Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Becton, Dickinson and Co (BDXB.PFD), the current OCF Margin % is 12.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
78GF Score
Get the complete analysis for BDXB.PFD
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDXB.PFD has been successfully added to your 
